Executive Pay: The Curious Case of Carlos Ghosn’s Arrest
February 12, 2025
Why are Indian Corporates struggling? It would be an understatement to state that Indian Corporates are struggling. Saddled with huge debt that they accumulated and binged on during the “boom” years, they are now also facing the challenges of operating in a low growth environment wherein they can neither pay off the debt as they […]
Since the entire premise of having a Six Sigma process is based on measurement, comparison of measurements and setting corrective action plans, it is crucial that the variables (metrics) being measured are appropriate. Wrong measurements lead to wrong decisions which are expensive and a wastage of time and resources. As explained in the Define module, […]
The e-pharmacy sector in India has been witnessing a lot of startup activity. More than 200 start-ups have sprung up in this space, and some of them have gained considerable resources. For example, 1mg has raised more than $50 million in seed funding from American private equity firms. Medlife, which is a similar start-up has […]
While coming up with operational metrics one must not forget to begin by first clarifying and defining what they mean. This is because there is a good chance that there may be ambiguity regarding what the metric really means. To better understand how to come up with operational definitions, the following procedure must be followed. […]
The fishbone diagram, which also goes by a couple of other names like the Cause and effect diagram and the Ishikawa diagram is one of the seven basic tools of quality management. It has wide ranging applications in almost all six sigma projects. The Fishbone diagram is a simple but highly effective tool in problem […]
The Indian pharmaceutical market is huge, and drugs worth billions of dollars are manufactured and sold every year in India. Some of these drugs are sold locally, and some are exported abroad.
India is the fourth largest pharmaceutical market in the world whereas it is also the largest exporter of pharmaceutical drugs worldwide. This rapidly growing pharmaceutical industry is the second most important economic sector for the Indian economy after the Information Technology sector. This is the reason why the Indian government has imposed fewer regulations on this sector. They want the cash flow to continue unabated.
However, recently, the United States has specifically pointed out to Indian counterfeit drugs. This is hurting the interests of the fledgling Indian pharmaceutical sector. Hence, the Indian government has come up with a counterclaim.
The Indian government has issued a statement wherein they officially do not agree with America’s accusation regarding counterfeit drugs. Instead, Indians claim that India is the leading source for low-cost generic medicines across the world.
In this article, we will have a closer look at the issue of drug counterfeiting as well as its impact over the economy as a whole.
According to American research, India is not only the largest exporter of pharmaceutical products but also holds a monopoly over counterfeit drugs. About 75% of all counterfeit drugs sold in the world originate from India.
It is estimated that Indian companies rake in $200 billion annually by selling counterfeit medicines. Even China is a distant second with less than 10% of the market share of counterfeit drugs.
The problem of counterfeit drugs is prevalent all across the world. However, it is more pronounced in developing nations. About 25% to 30% of all drugs sold in developing nations are counterfeit. On the other hand, only about 10% of the medicines sold in developed countries are counterfeit.
Nevertheless, counterfeit drugs are a menace in every part of the world. It is estimated that more than 300000 people lose their lives annually to this menace. Also, fake drugs are creating wellness problems for patients. Many times they have unwanted side effects creating medical nightmares.
There is no market in the world which is immune to counterfeiting. However, there are some reasons why counterfeiting has become so prevalent in India. They have been listed below:
This sector usually requires huge investments in research and technology. As such, it is not conducive to small and medium industries. This is the reason why the small and medium companies turn to counterfeit. Instead of developing new medicines and creating their own brands, many small companies just start counterfeiting the medicines produced by bigger and more well-known brands.
Counterfeit manufacturers do not have to share the branding expenses which result in the high price. This results in windfall gains for manufacturers who are able to replicate the drugs and the packaging of a well-known brand.
These counterfeit medicines have their own well developed distribution system as well. There are many markets in various parts of India which are well known for stocking up on and distributing counterfeit medicines.
The problem of counterfeit drugs is widespread and hence difficult to tackle. With the advent of technology, it may now be easier to respond to the threat of counterfeit drugs.
Under this system, a consumer purchasing a drug can take a picture of a barcode printed on the drug. This picture can then be uploaded to a website whereby the genuineness of the drug can be confirmed.
The problem with this approach is that the internet infrastructure in India is not very well developed. Also, there are relatively few literate people in India.
This approach will only work in major towns and cities. It will be difficult to implement this approach in smaller villages. The more important and monetarily significant export market will also benefit from the introduction of this technology.
Your email address will not be published. Required fields are marked *